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Novel synthetic anitmicrobial peptides against
streptococcus pneumoniae
H. Jindal ∗, S. Devi, R. Devi
University of Malaya, Kuala Lumpur, Malaysia
Background: According to WHO, 1.6 million deaths are caused
by pneumococcal infections every yearwith 0.7 to 1million in chil-
drenyounger than5yearsmostly inAsia andAfrica. Likeother gram
positive bacteria, Streptococcus pneumoniae is increasingly difﬁcult
to treat due to the irrational use of antibiotics. Antimicrobial pep-
tides (AMPs) represent a possible alternative for current antibiotics
against drug resistant pathogens.
Methods&Materials: In this study, thirteen antimicrobial pep-
tides were designed based on two natural peptides indolicidin
and ranalexin. the in vitro activity of these peptides was inves-
tigated using broth microdilution assay, hemolytic activity assay,
time killing assay, and toxicity assay against two cell lines WRL-68
and NL-20.
Mechanisms of action of peptides were assessed using trans-
mission electron microscopy (TEM), scanning electron microscopy
(SEM), DNA binding assay, and in silico molecular docking against
three virulent fators.
Results: Our results revealed that four hybrid peptides RN7-
IN10, RN7-IN9, RN7-IN8, and RN7-IN6 possess potent antibacterial
activity against 30 pneumococcal clinical isolates (MIC 7.81-
15.62g/ml). These four hybrid peptides showed broad spectrum
antibacterial activity (7.81g/ml) against S. aureus, methicillin
resistant S. aureus (MRSA), and E. coli. Furthermore, the time killing
assay results indicated that the hybrid peptides were able to elim-
inate S. pneumoniae within less than one hour which is faster than
the standard drugs erythromycin and ceftriaxone. The cytotoxic-
ity was tested against human erythrocytes, WRL-68 normal liver
cell line, and NL-20 normal lung cell line. The results revealed that
none of the thirteen peptides have cytotoxic or hemolytic activities
at their MICs.
TEMand SEM results showed that these four peptides are killing
the bacteria by destroying the integrity of thier membranes. DNA
binding assay evealed that the hybrid peptides were able to bind
to DNA at 62.5 g/ml preventing it from migration through the
agarosre gel.
The effect of hybrid peptides on the integrity of bacterial
membranes
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Conclusion: In conclusion, our results indicated that hybrid
peptides RN7-IN10, RN7-IN9, RN7-IN8, RN7-IN7 and RN7-IN6 rep-
resent promising ﬁrst templates for developing a new class of
antibacterial agents against S. pneumonia. Hence, with the grow-
ing resistance to traditional antibiotics, our peptides can offer an
alternative to today’s antibiotics to protect against resistant bacte-
ria
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Investigation of diverse carbapenem resistance
mechanisms in pseudomonas aeruginosa
isolated from a tertiary care centre in India
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Gopi2, B. Veeraraghavan2
1 Christian Medical College, Vellore, Tamilnadu, India
2 Christian Medical College, Vellore, India
Background: Emergence and spread of carbapenem resistance
in Psuedomonas aeruginosa is on the rise. Resistance mechanisms
for carbapenems are of various types. The most common are car-
bapenemase production, loss of porins and over-expression of
efﬂux pumps. Presence of each of these resistance mechanisms
contributes to various phenotypes such as imipenem resistant
but meropenem susceptible (IRMS), meropenem resistant but
imipenem susceptible (MRIS) and resistant to both imipenem and
meropenem (IRMR). This study was undertaken to investigate the
resistance mechanisms responsible for these different phenotypes
Methods & Materials: A total of 50 carbapenem resistant iso-
lates of P.aeruginosa were collected from blood and respiratory
samples of patients with ventilator associated pneumonia and/or
bacteremia. Of the ﬁfty isolates, 8 were IRMS, 3 were MRIS and
39 were IRMR phenotypes. Carbapenemase genes such as blaSPM,
blaIMP, blaVIM, blaNDM, blaKPC and blaOXA-48 were screened for all the
50 isolates. In addition, for 8 IRMS, sequencing of OprD was done
to look for the presence of mutations and relative quantiﬁcation
was done to quantify the OprD transcripts. While for three MRIS,
relative quantiﬁcation of mexAB efﬂux pump was done to quantify
the over expression
Results: Of the 50 isolates, carbapenem resistance due to car-
bapenemase enzymes was found to be only 22%, which was due to
blaVIM (n=7), blaNDM (n=3) and blaOXA-48 (n=1). Among the 8 IRMS
isolates, only one was a blaVIM producer and seven isolates har-
bored multiple mutations in oprD gene. In addition, quantiﬁcation
revealed that, down regulation of oprD gene transcriptswere found
in few isolates. While for MRIS isolates, mexAB pump was found to
be over-expressed
Conclusion: From this study we found that, IRMS is primarily
due to the mutations across various regions in the loops of OprD
gene,MRIS is due to the over expression ofmexAB efﬂux pumps and
IRMR is due to carbapenemases. This study results conﬁrms that,
these phenotypes are due to the different resistance mechanisms.
This study also emphasizes that preliminary disc diffusion should
be performed for both imipenem and meropenem particularly for
P.aeruginosa, rather than testing single agents, as the resistance
mechanisms for each of the agents are different
http://dx.doi.org/10.1016/j.ijid.2016.02.473
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Demonstration of horizontal gene transfer of
ﬂuoroquinolone resistance by plasmids in
clinical isolates of shigella spp. and salmonella
spp.
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Anandan2, B. Veeraraghavan2
1 Christian Medical College, Vellore, Tamil Nadu,
India
2 Christian Medical College, Vellore, India
Background: Shigella and Salmonella infections represent a
major health problem, particularly in the developing countries. 165
million cases of Shigella infection occur annually worldwide with
1.1 million deaths with most of the causality in children under 5
years of age. Plasmid mediated ﬂuoroquinolone resistance is on
the rise among enteric pathogens. This study was aimed to inves-
tigate the horizontal transfer of ﬂuoroquinolone resistant gene
harbouring plasmid from multi-drug resistant (MDR) Shigella spp.
to susceptible Salmonella spp., which are closely related among
diarrheal infections.
Methods & Materials: A total of 67 MDR Shigella spp. were
isolated from faeces samples from January to December 2014. Iso-
lates were identiﬁed by standard biochemical tests and further
serotyped by slide agglutination test with commercial antisera.
Antimicrobial susceptibility testing was performed as per Kirby-
